KEY PRODUCTS
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
01 1VENETOCLAX
01 1India
01 1Active
01 1Complete
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2020-02-13
Pay. Date : 2020-01-21
DMF Number : 33669
Submission : 2019-03-29
Status : Active
Type : II
20
Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is VENETOCLAX, with a corresponding US DMF Number 33669.
Remarkably, this DMF maintains an Active status since its submission on March 29, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 13, 2020, and payment made on January 21, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
